← Browse by Condition
Medical Condition

crimean congo hemorrhagic fever

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06799013 Phase 1
Recruiting

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Enrollment
48 pts
Location
United States
Sponsor
HDT Bio
View Trial →